SCHEMBL2803194

SCHEMBL2803194

CS(=O)(=O)NC(=O)c1cnn2c(NCc3ccccc3)c(C(=O)N3CCC4(CC3)OCc3ccccc34)cnc12

nearest known ligand 0.45

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 12/20 0.45
AVPR2 P30518 1/20 0.45
SPR P35270 1/20 0.44
OPRL1 P41146 3/20 0.41
OXTR P30559 1/20 0.39
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2799905 0.92 AVPR1A (0.46) AVPR1AAVPR2SPROPRL1OXTR
SCHEMBL2803834 0.87 RBP4 (0.40) OPRL1
SCHEMBL2801650 0.87 AVPR1A (0.46) AVPR1AAVPR2SPROPRL1OXTR
SCHEMBL2804011 0.87 NPY5R (0.42) AVPR1A
SCHEMBL2801158 0.85 AVPR1A (0.43) AVPR1AAVPR2SPROPRL1OXTR
SCHEMBL2801247 0.84 IDO1 (0.39) AVPR1A
SCHEMBL2803842 0.84 SCD5 (0.36) SPR
SCHEMBL2800930 0.84 MCHR2 (0.39) OXTR
SCHEMBL2802503 0.84 CCR5 (0.34)
SCHEMBL2799969 0.83 ALDH1A1 (0.34) SPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 AVPR1A 4789/4885AVPR2 4608/4885SPR 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.